Barclays lowered the firm’s price target on Clarivate (CLVT) to $4 from $5 and keeps an Underweight rating on the shares. The company reported “poor” Q4 results, pulled guidance, “questionable” buybacks, and a “Value Creation Plan” that does not appear large enough in scope to make a material difference, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue